Monthly Archives: June 2023
News
U.S. FDA approves Celltrion’s AVTOZMA, a biosimilar to ACTEMRA
The U.S. Food and Drug Administration (FDA) has approved Celltrion's AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a...
hVIVO signs RSV human challenge trial contract with Inhalon Biopharma
hVIVO, a specialist contract research organisation (CRO), has signed a contract with Inhalon Biopharma, a clinical-stage company advancing a first-in-class inhaled antibody platform for...
Sarclisa becomes first anti-CD38 treatment approved in China for patients with newly diagnosed multiple...
The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the...
